Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy

References

• Abuizzah K., Lu D. R. High performance liquid chromatographic determination of sodium mercaptoundecahydrododecaborate with precolumn derivatization. Journal of Chromatography, Biomedical Applications, 660(2)347–352
   Google Scholar
• Alam F., Bapat B. V., Soloway A. M., Barth R. F., Mafune N., Adams D. M. Boronated compounds for neutron capture therapy. Strahlentherapie und Onkologie 1989a; 165: 121–123
   PubMedGoogle Scholar
• Alam F., Soloway A. H., Barth R. F., Mafune N., Adams D. M., Knoth W. H. Boron neutron capture therapy: linkage of a boronated macromolecule to monoclonal antibodies directed against tumor associated antigens. Journal of Medical Chemistry 1989b; 32: 2326–2330
   PubMed Web of Science ®Google Scholar
• Allen T. M., Mehra T., Hansen C., Chin Y. C. Stealth liposomes: An improved sustained release system for 1 -β-d-arabinofuranosylcytosine. Cancer Research 1992; 52: 2431–2439
   PubMed Web of Science ®Google Scholar
• Barth R. F., Soloway A. H., Fairchild R. G. Boron neutron capture therapy for cancer. Cancer Research 1990; 50: 1061–1070
   PubMed Web of Science ®Google Scholar
• Gabizon A., Price D. C., Huberty J., Bresalier R. S., Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies. Cancer Research 1990; 50: 6371–6378
   PubMed Web of Science ®Google Scholar
• Gregoire V., Begg A. C., Huiskamp R., Verrijk R., Bartelink H. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors. Radiotherapy and Oncology 1993; 27: 46–54
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Overview of liposomes. Journal of Antimicrobial Chemotherapy 1991; 28: 39–54, (Suppl. B)
   PubMed Web of Science ®Google Scholar
• Gregoriadis G., Florence A. T. Liposomes and cancer therapy. Cancer Cells 1991; 2(4)144–146
   Google Scholar
• Gregoriadis G., Florence A. T. Liposomes in drug delivery: Clinical, diagnostic and ophthalmic potential. Drugs 1993; 45(1)15–28
   PubMed Web of Science ®Google Scholar
• Harashima H., Sawada Y., Sugiyama H., Iga T., Hanano M. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1985; 13: 425–440
   PubMedGoogle Scholar
• Ichihashi M., Nakanishi T., Mishima Y. Specific killing of 10B-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vivo radiological evaluation. Journal of Investigative Dermatology 1982; 78: 215–218
   PubMedGoogle Scholar
• Kahl S. B., Joel D. D., Nawrocky M. M., Micca P. L., Tran K. P., Finkel G. C. Uptake of a nido-carboranylporphyrine by human glioma xenografts in athymic nude mice and by synergistic ovarian carcinomas in immunocompetent mice. Proceedings of the National Academy of Science, USA 1990; 87: 7265–7269
   PubMed Web of Science ®Google Scholar
• LaHann T. R., Lu D. R., Daniell G., Sills C., Kraft S. L., Gavin P. R., Bauer W. F. Bioavailability of intravenous formulations of p-Boronophenylalanine in dog and rat. Advances in Neutron Capture Therapy, R. F. Barth, A. H. Soloway. Plenum Press, New York 1993; 585–589
   Google Scholar
• LaHann T., Bauer W. F., Lu D. R. Pharmacokinetics of boronophenylalanine delivered in HP-β-cyclodentrin formulation. Polymeric Drugs and Drug Delivery Systems, R. M. Ottenbrite. ACS Book Series 545, American Chemical Society, Washington, DC 1994; 66–78
   Google Scholar
• Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochimica et Biophysica Acta 1992; 1128: 44–49
   PubMed Web of Science ®Google Scholar
• Mehta S. C., Boudinot F. D., Lu D. R. Pharmacokinetics of sodium mercaptoundecahydrododecaborate (BSH) after intravenous injection in rats. Drug Metabolism and Disposition 1995, (In press)
   PubMedGoogle Scholar
• Mishima Y. Neutron capture treatment of malignant melnoma using 10B-chlorpromazine compound. Pigment Cell, V. Riley. Karger, Basel 1983; 215–221
   Google Scholar
• Mori A., Klibanov A. L., Torchilin V. P., Huang L. Influence of the steric barrier activity of amphipathic poly(ethylene glycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes. in vivo. FEBS Letters 1991; 284(2)263–266
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D., Gabizon A. Targeting of liposomes to tumor cells. in vivo. Annals of the New York Academy of Science 1987; 507: 64–74
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D., Allen T. M., Gabizon A., Mayhew E., Matthay K., Huang S. K., Lee K. D., Woodle M. C., Lasic D. D., Redemann C., Martin F. J. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proceedings of the National Academy of Science, USA 1991; 88: 11460–11464
   PubMed Web of Science ®Google Scholar
• Saini P., Abuizzah K., Lu D. R. High performance liquid chromatographic assay for sodium mercaptoundecahydrododecaborate in rat tissues. Journal of Chromatography, Biomedical Applications 1995; 665: 155–161
   Google Scholar
• Schinazi R. F., Prusoff W. H. Synthesis and properties of boron and silicon substituted uracil or 2-deonyuridine. Tetrahedron Letters 1978; 50: 4981–4984
   Google Scholar
• Shelly E., Feaks D. A., Hawthorne M. F., Schmidt P. G., Krisch T. A., Bauer W. F. Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes. Proceedings of the National Academy of Science, USA 1992; 89: 9039–9043
   PubMed Web of Science ®Google Scholar
• Soloway A. H., Hatanaka H., Davis M. A. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. Journal of Medical Chemistry 1967; 10: 714–717
   PubMed Web of Science ®Google Scholar
• Spielvogel B. F., Good A., Hall I. H., Fairchild R. G., Micca P. L. Synthesis, antineoplastic activity and biodistribution of boron analogues of amino acids and related compounds. Strahlentherepie und Onkologie 1989; 165: 123–125
   PubMed Web of Science ®Google Scholar
• Tjarks W., Gabel D. Boron-containing thiouracil derivatives for neutroncapture therapy of melanoma. Journal of Medical Chemistry 1991; 34: 315–319
   PubMed Web of Science ®Google Scholar
• Varadarajan A., Sharkey R. M., Goldenberg D. M., Hawthorne M. D. Conjugation of phenyl isothiocyanate derivatives of carborate to antitumor antibody and in-vivo localization of conjugates in nude mice. Bioconjugate Chemistry 1991; 2: 102–110
   PubMed Web of Science ®Google Scholar
• Woodle M. C., Lasic D. D. Sterically stabilized liposomes. Biochimica et Biophysica Acta 1992; 1113: 171–199
   PubMed Web of Science ®Google Scholar
• Wu N. Z., Da D., Rudoll T. L., Needham D., Whorton A. P., Dewhirst M. W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Research 1993; 53: 3765–3770
   PubMed Web of Science ®Google Scholar
• Yanagie H., Tomita T., Kobayashi H., Fuji F., Takahashi T., Hasumi K., Nariuchi H., Sekiguchi M. Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in vitro boron neutron capture therapy model. British Journal of Cancer 1991; 63: 522–526
   PubMed Web of Science ®Google Scholar